Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10777 | 31197470 | Acta Diabetol | Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients. | 2019 | Details |
| A10779 | 31197160 | Cell Death Dis | Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans. | 2019 | Details |
| A10780 | 31197036 | J Biol Chem | Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease. | 2019 | Details |
| A10781 | 31196707 | Clin Res Hepatol Gastroenterol | Non-Alcoholic Fatty Liver Disease in Non-Obese Individuals: Prevalence, Pathogenesis and Treatment. | 2019 | Details |
| A10782 | 31195981 | Mol Med | miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. | 2019 | Details |
| A10783 | 31195434 | Gut Liver | Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A10784 | 31195161 | Clin Gastroenterol Hepatol | Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis. | 2019 | Details |
| A10785 | 31195117 | Biochim Biophys Acta Mol Basis Dis | Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis. | 2019 | Details |
| A10786 | 31193303 | J Adv Res | Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review. | 2018 | Details |
| A10787 | 31191837 | Gastroenterol Hepatol Bed Bench | ANXA2, PRKCE, and OXT are critical differentially genes in Nonalcoholic fatty liver disease. | 2019 | Details |
| A10788 | 31191836 | Gastroenterol Hepatol Bed Bench | Pro-oxidant antioxidant balance in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A10789 | 31191607 | Front Genet | Transcriptional Repression of CYP3A4 by Increased miR-200a-3p and miR-150-5p Promotes Steatosis in vitro. | 2019 | Details |
| A10790 | 31191550 | Front Immunol | Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A10791 | 31191364 | Front Physiol | Irbesartan Ameliorates Lipid Deposition by Enhancing Autophagy via PKC/AMPK/ULK1 Axis in Free Fatty Acid Induced Hepatocytes. | 2019 | Details |
| A10792 | 31191323 | Front Pharmacol | Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10793 | 31190566 | Arch Physiol Biochem | High-carbohydrate diet-induced metabolic disorders in Gerbillus tarabuli (a new model of non-alcoholic fatty-liver disease). Protective effects of 20-hydroxyecdysone. | 2019 | Details |
| A10794 | 31189885 | Cell Death Dis | Ets-1 deficiency alleviates nonalcoholic steatohepatitis via weakening TGF-β1 signaling-mediated hepatocyte apoptosis. | 2019 | Details |
| A10795 | 31189495 | Clin Nutr | Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system. | 2019 | Details |
| A10796 | 31188634 | Am J Physiol Gastrointest Liver Physiol | Combination of CCl4 with alcoholic and metabolic injuries mimics human liver fibrosis. | 2019 | Details |
| A10797 | 31187872 | Folia Histochem Cytobiol | The immunoreactivity of TGF-b1 in non-alcoholic fatty liver disease. | 2019 | Details |
| A10798 | 31187710 | Curr Protein Pept Sci | System Bioinformatic Approach Through Molecular Docking, Network Pharmacology and Microarray Data Analysis to Determine the Molecular Mechanism Underlying the Effects of Rehmanniae Radix Praeparata on Cardiovascular Diseases. | 2019 | Details |
| A10799 | 31187324 | Dig Dis Sci | Awareness of Nonalcoholic Fatty Liver Disease Is Increasing but Remains Very Low in a Representative US Cohort. | 2019 | Details |
| A10800 | 31185686 | Nutrients | A New Light on Vitamin D in Obesity: A Novel Association with Trimethylamine-N-Oxide (TMAO). | 2019 | Details |
| A10802 | 31185249 | Cancer Lett | New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer. | 2019 | Details |
| A10803 | 31184438 | Pediatr Obes | Nonalcoholic fatty liver disease and eGFR levels could be linked by the PNPLA3 I148M polymorphism in children with obesity. | 2019 | Details |
| A10804 | 31182918 | Int J Biol Sci | A Comprehensive Study of High Cholesterol Diet-Induced Larval Zebrafish Model: A Short-Time In Vivo Screening Method for Non-Alcoholic Fatty Liver Disease Drugs. | 2019 | Details |
| A10805 | 31181878 | Korean J Intern Med | Pilot study: asymptomatic hyperuricemia patients with obesity and nonalcoholic fatty liver disease have increased risk of double contour sign. | 2019 | Details |
| A10806 | 31181641 | J Clin Med | Bile Acid and Fibroblast Growth Factor 19 Regulation in Obese Diabetics, and Non-Alcoholic Fatty Liver Disease after Sleeve Gastrectomy. | 2019 | Details |
| A10807 | 31180545 | Mol Med Rep | LRG ameliorates steatohepatitis by activating the AMPK/mTOR/SREBP1 signaling pathway in C57BL/6J mice fed a high‑fat diet. | 2019 | Details |
| A10808 | 31178720 | Front Pharmacol | Role of Natural Phenolics in Hepatoprotection: A Mechanistic Review and Analysis of Regulatory Network of Associated Genes. | 2019 | Details |
| A10809 | 31178295 | Med Clin (Barc) | Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care. | 2019 | Details |
| A10810 | 31177662 | Zhonghua Gan Zang Bing Za Zhi | [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease]. | 2019 | Details |
| A10811 | 31177658 | Zhonghua Gan Zang Bing Za Zhi | [Prevalence and risk factors of nonalcoholic fatty liver disease in patients with chronic hepatitis B receiving antiviral therapy]. | 2019 | Details |
| A10812 | 31177593 | Traffic | Metabolic regulation through the endosomal system. | 2019 | Details |
| A10813 | 31176759 | Mol Cell Endocrinol | Adiponectin is required for pioglitazone-induced improvements in hepatic steatosis in mice fed a high-fat diet. | 2019 | Details |
| A10814 | 31176631 | Dig Liver Dis | Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review. | 2019 | Details |
| A10815 | 31176297 | Eur J Endocrinol | Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study. | 2019 | Details |
| A10816 | 31176163 | Biomed Pharmacother | Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A10817 | 31175629 | Curr Obes Rep | Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives. | 2019 | Details |
| A10818 | 31175077 | Arab J Gastroenterol | Egyptian liver library: An indexed database for liver disease evidence in Egypt. | 2019 | Details |
| A10819 | 31173696 | Appl Physiol Nutr Metab | Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway. | 2019 | Details |
| A10820 | 31173506 | FASEB J | Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans. | 2019 | Details |
| A10821 | 31173462 | Cytometry B Clin Cytom | A Novel Automatic Digital Algorithm that Accurately Quantifies Steatosis in NAFLD on Histopathological Whole-Slide Images. | 2019 | Details |
| A10822 | 31173200 | Mol Med Rep | Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice. | 2019 | Details |
| A10823 | 31173180 | Int J Mol Med | Excess fructose and fatty acids trigger a model of non‑alcoholic fatty liver disease progression in vitro: Protective effect of the flavonoid silybin. | 2019 | Details |
| A10824 | 32812939 | Metabol Open | Nonalcoholic fatty liver disease in obese adolescent females is associated with multi-tissue insulin resistance and visceral adiposity markers. | 2019 | Details |
| A10825 | 31172417 | Hepatol Int | Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. | 2019 | Details |
| A10826 | 31171889 | World J Gastroenterol | Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats. | 2019 | Details |
| A10827 | 31170503 | Biochim Biophys Acta Mol Cell Biol Lipids | Turnover of bile acids in liver, serum and caecal content by high-fat diet feeding affects hepatic steatosis in rats. | 2019 | Details |
| A10828 | 31169972 | Liver Int | Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity. | 2019 | Details |
| A10829 | 31169533 | Am J Gastroenterol | Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10830 | 31168893 | J Magn Reson Imaging | Diurnal Variation of Proton Density Fat Fraction in the Liver Using Quantitative Chemical Shift Encoded MRI. | 2019 | Details |
| A10831 | 31168845 | J Cell Biochem | Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial. | 2019 | Details |
| A10832 | 31168625 | Carcinogenesis | Sex hormone-binding globulin suppresses NAFLD-triggered hepatocarcinogenesis after menopause. | 2019 | Details |
| A10833 | 31168511 | Hepatol Commun | Lipocalin-2 Protects Against Diet-Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes. | 2019 | Details |
| A10835 | 31165837 | Food Funct | Sinapine reduces non-alcoholic fatty liver disease in mice by modulating the composition of the gut microbiota. | 2019 | Details |
| A10836 | 31165323 | Eur J Epidemiol | Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink. | 2019 | Details |
| A10837 | 31164707 | Eur J Clin Nutr | Associations between serum lipophilic antioxidants levels and non-alcoholic fatty liver disease are moderated by adiposity. | 2019 | Details |
| A10838 | 31164564 | Methods Protoc | Establishment of Orthotopic Liver Tumors by Surgical Intrahepatic Tumor Injection in Mice with Underlying Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A10839 | 31163711 | Medicina (Kaunas) | A Simple Index for Nonalcoholic Steatohepatitis-HUFA-Based on Routinely Performed Blood Tests. | 2019 | Details |
| A10840 | 31163617 | Int J Mol Sci | Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model. | 2019 | Details |
| A10841 | 31162812 | Liver Int | Nonalcoholic steatohepatitis is associated with a higher risk of advanced colorectal neoplasm. | 2019 | Details |
| A10842 | 31162803 | Liver Int | Association between nut consumption and non-alcoholic fatty liver disease in adults. | 2019 | Details |
| A10844 | 31161464 | Neurochem Res | Food Selection of Cafeteria Diet Affects Memory Dysfunction Related to Obesity. | 2019 | Details |
| A10845 | 31161349 | Eur J Nutr | Moderate chronic ethanol consumption exerts beneficial effects on nonalcoholic fatty liver in mice fed a high-fat diet: possible role of higher formation of triglycerides enriched in monounsaturated fatty acids. | 2019 | Details |
| A10846 | 31160348 | Cancer Epidemiol Biomarkers Prev | Association between Liver Fibrosis and Serum PSA among U.S. Men: National Health and Nutrition Examination Survey (NHANES), 2001-2010. | 2019 | Details |
| A10847 | 31160124 | Trends Pharmacol Sci | Genetic Insights for Drug Development in NAFLD. | 2019 | Details |
| A10849 | 31157605 | J Am Coll Nutr | Association Between Dietary Selenium Intake and the Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. | 2019 | Details |
| A10850 | 31157422 | Aliment Pharmacol Ther | Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis. | 2019 | Details |
| A10851 | 31156626 | Front Immunol | Chronic Liver Disease in Humans Causes Expansion and Differentiation of Liver Lymphatic Endothelial Cells. | 2019 | Details |
| A10852 | 31156558 | Front Endocrinol (Lausanne) | Countering the Modern Metabolic Disease Rampage With Ancestral Endocannabinoid System Alignment. | 2019 | Details |
| A10853 | 31155826 | Liver Int | Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: The Framingham Study. | 2019 | Details |
| A10854 | 31155687 | Dig Dis Sci | Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis. | 2019 | Details |
| A10855 | 31155606 | Exp Anim | Analysis of amino acid profiles of blood over time and biomarkers associated with non-alcoholic steatohepatitis in STAM mice. | 2019 | Details |
| A10856 | 31153716 | Ultrasound Med Biol | The Speed of Sound in Rat Liver With Steatohepatitis: Ex Vivo Analysis Using Two Types of Ultrasound Systems. | 2019 | Details |
| A10857 | 31153702 | J Vasc Surg | The association between liver fat and systemic calcified atherosclerosis. | 2019 | Details |
| A10858 | 31153607 | Med Clin (Barc) | Relationship between hypothyroidism and non-alcoholic fatty liver disease in the Spanish population. | 2019 | Details |
| A10859 | 31153588 | Acta Histochem | A histomorphometric study on the hepatoprotective effects of a green rooibos extract in a diet-induced obese rat model. | 2019 | Details |
| A10860 | 31152791 | Free Radic Biol Med | Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease. | 2019 | Details |
| A10863 | 31151875 | Ann Hepatol | Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population. | 2019 | Details |
| A10864 | 32953568 | J Tradit Complement Med | Calcium supplementation shows a hepatoprotective effect against high-fat diet by regulating oxidative-induced inflammatory response and lipogenesis activity in male rats. | 2019 | Details |
| A10865 | 31151002 | J Mech Behav Biomed Mater | Biomechanics of cultured hepatic cells during different steatogenic hits. | 2019 | Details |
| A10866 | 31150631 | Chem Biol Interact | β-ionone inhibits nonalcoholic fatty liver disease and its association with hepatocarcinogenesis in male Wistar rats. | 2019 | Details |
| A10868 | 31149745 | Aliment Pharmacol Ther | Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications. | 2019 | Details |
| A10869 | 31149341 | Pharmacol Res Perspect | A structured literature review of interventions used in the management of nonalcoholic steatohepatitis (NASH). | 2019 | Details |
| A10870 | 32818162 | Curr Opin Physiol | Redox Regulation of Metabolic Syndrome: Recent Developments in Skeletal Muscle Insulin Resistance and Non-alcoholic Fatty Liver Disease (NAFLD). | 2019 | Details |
| A10871 | 31147590 | Sci Rep | Effects of açai on oxidative stress, ER stress, and inflammation-related parameters in mice with high fat diet-fed induced NAFLD. | 2019 | Details |
| A10872 | 31146627 | Prog Transplant | Effects of Share 35 Policy on Liver Transplantation Outcomes for Patients With Nonalcoholic Steatohepatitis. | 2019 | Details |
| A10873 | 31145929 | J Hepatol | Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification. | 2019 | Details |
| A10874 | 31145699 | JCI Insight | A randomized 3-way crossover study indicates that high-protein feeding induces de novo lipogenesis in healthy humans. | 2019 | Details |
| A10875 | 31145689 | Drug Metab Pers Ther | The effect of curcumin with piperine supplementation on pro-oxidant and antioxidant balance in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial. | 2019 | Details |
| A10876 | 31144451 | J Cell Mol Med | Alisol A attenuates high-fat-diet-induced obesity and metabolic disorders via the AMPK/ACC/SREBP-1c pathway. | 2019 | Details |
| A10877 | 31144415 | Hepatol Res | Autotaxin is a valuable biomarker for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A10878 | 31144261 | Curr Obes Rep | Ethnic Disparities in Adiposity: Focus on Non-alcoholic Fatty Liver Disease, Visceral, and Generalized Obesity. | 2019 | Details |
| A10879 | 31143330 | Pan Afr Med J | Non alcoholic fatty liver disease in a young male with celiac disease. | 2019 | Details |
| A10881 | 31142491 | BMJ Case Rep | Homeopathy-medicine induced severe alcoholic hepatitis. | 2019 | Details |
| A10882 | 31142104 | Clin Mol Hepatol | Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with type 2 diabetes. | 2019 | Details |
| A10884 | 31141077 | Arq Gastroenterol | THE CORRELATION OF NECK CIRCUMFERENCE AND INSULIN RESISTANCE IN NAFLD PATIENTS. | 2019 | Details |
| A10885 | 31141073 | Arq Gastroenterol | 18F-FDG PET/CT AS AN ASSESSMENT TOOL OF HEPATOCELLULAR CARCINOMA SECONDARY TO NON-ALCOHOLIC FATTY LIVER DISEASE DEVELOPMENT IN EXPERIMENTAL MODEL. | 2019 | Details |
| A10886 | 31140156 | Hormones (Athens) | Non-alcoholic fatty liver infiltration in children: an underdiagnosed evolving disease. | 2019 | Details |